Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms

Frontiers in Medicine(2022)10.3389/fmed.2022.973964Source: DataRank Database

An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms is a research paper published in Frontiers in Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 48 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access48 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 5.44)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Beth L. Roman ORCID,Helen M. Arthur ORCID

Live enrichment

PubMed:36250069 PMC:PMC9556665 OpenAlex:https://openalex.org/W4298005499

British Heart Foundation

Grant: PG/18/57/33941

NHLBI NIH HHS

Grant: R01 HL136566

NHLBI NIH HHS

Grant: R01 HL133009

National Institutes of Health

Grant: 1R01HL136566-01

Interaction between blood flow and ALK1 signaling in AVM development

National Institutes of Health

Grant: 5R01HL133009-02

BMP10 IN CARDIOVASCULAR DEVELOPMENT AND HEREDITARY HEMORRHAGIC TELANGIECTASIA

U.S. Department of Defense

British Heart Foundation

National Institutes of Health

FWCI

5.44

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fmed.2022.973964/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fmed.2022.973964/pdf

journalhttps://doi.org/10.3389/fmed.2022.973964

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36250069

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9556665

Fields of Study

Vascular Anomalies and TreatmentsTracheal and airway disordersVascular Malformations and Hemangiomas0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

EndoglinPhenotypeCancer researchHaploinsufficiencyPoint mutationTelangiectasiaVascular remodelling in the embryoMedicineACVRL1BiologyMutationPathologyCell biologyGeneGeneticsStem cellCD34HhtEndoglin (Cd105)Arteriovenous Malformation (Avm)Activin Receptor-like Kinase 1 (Acvrl1)Bmp-Smad Signalling PathwayCell Polarity And MigrationMedicine (General)R5-920

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms

FAIR Checklist

Authors (2)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)